Srikanth Reddy Janga (Srikanth R Janga)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 7

Top Venues

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Scientific reports

Biomacromolecules

Molecular pharmaceutics

University of Southern California

University of Southern California School of Pharmacy (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southern California Mar 01 2017

United States

Research Lab Specialist :: Ophthalmology

University of Southern California Nov 15 2015 - Feb 28 2017

United States

Research Lab Technician III :: Ophthalmology

University of Southern California School of Pharmacy Oct 31 2010 - Nov 14 2015

United States

research Lab Technician III :: Pharmaceutical Sciences

Education History

University of Southern California School of Pharmacy Aug 04 2007 - Jan 12 2010

United States

MSC :: Pharmaceutical Sciences

Publications

Yaping Ju, Maria C Edman, Hao Guo, Srikanth Reddy Janga, Santosh Peddi, Stan G Louie, Jason A Junge, John Andrew MacKay, Sarah F Hamm-Alvarez
Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome. Biomacromolecules 22 (3) (2020)
Wannita Klinngam, Srikanth Reddy Janga, Changrim Lee, Yaping Ju, Frances Yarber, Mihir Shah, Hao Guo, Dandan Wang, John Andrew MacKay, Maria C Edman, Sarah F Hamm-Alvarez
Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome. Scientific reports 9 (1) (2019)
Changrim Lee, Hao Guo, Wannita Klinngam, Srikanth Reddy Janga, Frances Yarber, Santosh Peddi, Maria C Edman, Nishant Tiwari, Siyu Liu, Stan G Louie, Sarah F Hamm-Alvarez, John Andrew MacKay
Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease. Molecular pharmaceutics 16 (7) (2019)
Srikanth Reddy Janga, Sarah F Hamm-Alvarez
PP2A: A Novel Target to Prevent Cathepsin S-mediated Damage in Smoking-induced Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine 200 (1) (2019)
Yaping Ju, Hao Guo, Frances Yarber, Maria C Edman, Santosh Peddi, Srikanth Reddy Janga, John Andrew MacKay, Sarah F Hamm-Alvarez
Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide. Bioconjugate chemistry 30 (9) (2019)
Srikanth Reddy Janga, Mihir Shah, Yaping Ju, Zhen Meng, Maria C Edman, Sarah F Hamm-Alvarez
Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 24 (1) (2018)
Wannita Klinngam, Runzhong Fu, Srikanth Reddy Janga, Maria C Edman, Sarah F Hamm-Alvarez
Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells. International journal of molecular sciences 19 (11) (2018)

Srikanth Reddy Janga.css-eqlu8i{font-size:small;padding-left:4px;} (Srikanth R Janga)

Publication Activity (10 Years)

Top Topics

Top Venues

Srikanth Reddy Janga (Srikanth R Janga)